Bleomycin NDC 0143-9240

NDC codes

FDA NDC Directory

Product NDC (as listed)0143-9240Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00143-9240Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0143-9240-01	00143924001	1 VIAL in 1 BOX, UNIT-DOSE (0143-9240-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIALMarketed from Jan 9, 2018

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bleomycin
Generic name (nonproprietary): bleomycin
Active ingredients: Bleomycin sulfate — 15 [USP'U]/1
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intramuscular, Intrapleural, Intravenous, Subcutaneous
Labeler: Hikma Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065042
Marketing start: Jan 9, 2018
Listing expires: Dec 31, 2026
Identifiers: Product ID 0143-9240_c8047994-3b3a-4e16-809b-786e47014fe9SPL ID c8047994-3b3a-4e16-809b-786e47014fe9SPL set ID cccfb763-79fa-4186-89fb-d8d061d3c161RxCUI 1726673, 1726676UNII 7DP3NTV15T
Pharmacologic class: Cytoprotective Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400143924001 followed by a unit qualifier and the quantity

Package 00143-9240-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 11, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Bleomycin for Injection, USP should be considered a palliative treatment. It has been shown to be useful in the management of the Squamous Cell Carcinoma Head and neck (including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingivae, epiglottis, skin, larynx), penis, cervix, and vulva. The response to bleomycin is poorer in patients with previously irradiated head and neck cancer. Lymphomas Hodgkin's disease, non-Hodgkin's lymphoma. Testicular Carcinoma Embryonal cell, choriocarcinoma, and teratocarcinoma. Bleomycin for Injection, USP has also been shown to be useful in the management of: Malignant Pleural Effusion Bleomycin is effe…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065042

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065042
Product	Strength	Form · route	Labeler	Product NDC
Bleomycin	Bleomycin sulfate 30 [USP'U]/1	Injection, Powder, Lyophilized, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous	Hikma Pharmaceuticals USA Inc.	0143-9241